ROS1 and central nervous system cancer: In addition, we did not investigate whether wild-type KLC1 contributes to the oncogenicity of KLC1-ROS1 fusion-harboring glioma cells, although our current data suggest an essential role for the KLC1 domain in the activation of KLC1-ROS1 fusion.